Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.
Galiè N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, Espinola-Zavaleta N, Rocchi G, Manes A, Frantz R, Kurzyna M, Nagueh SF, Barst R, Channick R, Dujardin K, Kronenberg A, Leconte I, Rainisio M, Rubin L. Galiè N, et al. Among authors: hinderliter al. J Am Coll Cardiol. 2003 Apr 16;41(8):1380-6. doi: 10.1016/s0735-1097(03)00121-9. J Am Coll Cardiol. 2003. PMID: 12706935 Free article. Clinical Trial.
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.
Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jöbsis MM, Crow JW, Long W. Raymond RJ, et al. Among authors: hinderliter al. J Am Coll Cardiol. 2002 Apr 3;39(7):1214-9. doi: 10.1016/s0735-1097(02)01744-8. J Am Coll Cardiol. 2002. PMID: 11923049 Free article. Clinical Trial.
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.
Hinderliter AL, Willis PW 4th, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jöbsis MM, Blackburn SD Jr, Crow JW, Long WA. Hinderliter AL, et al. Circulation. 1997 Mar 18;95(6):1479-86. doi: 10.1161/01.cir.95.6.1479. Circulation. 1997. PMID: 9118516 Clinical Trial.
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension.
Hinderliter AL, Willis PW 4th, Long W, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Biosblanc B, Koch G, Li S, Clayton LM, Jöbsis MM, Crow JW. Hinderliter AL, et al. Am J Cardiol. 1999 Aug 15;84(4):481-4, A10. doi: 10.1016/s0002-9149(99)00342-2. Am J Cardiol. 1999. PMID: 10468096 Clinical Trial.
Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers.
Lee CR, Bass A, Ellis K, Tran B, Steele S, Caughey M, Stouffer GA, Hinderliter AL. Lee CR, et al. Among authors: hinderliter al. Am J Cardiol. 2012 Mar 1;109(5):651-7. doi: 10.1016/j.amjcard.2011.10.023. Epub 2011 Dec 6. Am J Cardiol. 2012. PMID: 22154090 Free PMC article.
Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension.
Hinderliter AL, Willis PW 4th, Long WA, Clarke WR, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Koch G, Li S, Clayton LM, Jöbsis MM, Crow JW; PPH Study Group. Hinderliter AL, et al. Am J Cardiol. 2003 Apr 15;91(8):1033-7, A9. doi: 10.1016/s0002-9149(03)00136-x. Am J Cardiol. 2003. PMID: 12686360 No abstract available.
266 results